This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignees: Cspc Nbp Pharmaceutical Co., Ltd., Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Surui Chen: Innovator in Pharmaceutical Formulations
Introduction
Surui Chen is a notable inventor based in Shijiazhuang, China. He has made significant contributions to the field of pharmaceutical formulations, particularly through his innovative work on soft capsules.
Latest Patents
One of Surui Chen's key patents is for a soft capsule of butylphthalide and a process for preparing the same. This invention discloses a novel soft capsule composed of a capsule wall material and a drug-containing oil. The drug-containing oil primarily consists of butylphthalide and a vegetable oil as a diluent, in a weight ratio of about 1:0.10. The capsule wall material includes a matrix, a plasticizer, and water, in a weight ratio of 1:0.2-0.4:0.8-1.3. This innovative soft capsule effectively masks the strong flavor of butylphthalide and addresses the challenges of formulating oily active ingredients into other oral formulations. The disintegration time of the soft capsule meets the requirements set by the Pharmacopoeia of P.R. China.
Career Highlights
Surui Chen has worked with prominent companies in the pharmaceutical industry, including Cspc Zhongqi Pharmaceutical Technology Co., Ltd. and Cspc Nbp Pharmaceutical Co., Ltd. His experience in these organizations has contributed to his expertise in drug formulation and development.
Collaborations
Surui Chen has collaborated with notable colleagues such as Jianqing Li and Min Bai, further enhancing his contributions to the field.
Conclusion
Surui Chen's innovative work in the development of soft capsules demonstrates his commitment to advancing pharmaceutical formulations. His contributions are significant in addressing the challenges faced in the industry, and his patent reflects his expertise and dedication to improving drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile